CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Sarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chapter","$":{"href":"/pharma/sarepta-taps-abbvie-tessera-vet-severino-write-duchenne-firms-next-chapter","hreflang":"en"}}]}

Neutral
AI Analysis

Summary

Sarepta Therapeutics has appointed Severino, a veteran from AbbVie and Tessera Technologies, as permanent CEO to replace retiring long-time CEO Doug Ingram.

Importance:3/10
Sentiment:
0.00
leadershipCEO transitionmanagement changeDuchenne muscular dystrophy
Related Companies

Read the original article

Published by FiercePharma on July 27, 2026 11:39 AM

Read Original